| Year |
Citation |
Score |
| 2019 |
Ding L, Su Y, Fassl A, Hinohara K, Qiu X, Harper NW, Huh SJ, Bloushtain-Qimron N, Jovanović B, Ekram M, Zi X, Hines WC, Alečković M, Gil Del Alcazar C, Caulfield RJ, et al. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. Nature Communications. 10: 4182. PMID 31519911 DOI: 10.1038/S41467-019-12125-5 |
0.368 |
|
| 2019 |
Ding L, Shunkwiler LB, Harper NW, Zhao Y, Hinohara K, Huh SJ, Ekram MB, Guz J, Kern MJ, Awgulewitsch A, Shull JD, Smits BMG, Polyak K. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment. Plos Genetics. 15: e1008002. PMID 30893315 DOI: 10.1371/Journal.Pgen.1008002 |
0.41 |
|
| 2018 |
Alcazar CRGd, Huh S, Ekram MB, Trinh A, Liu LL, Beca F, Xiaoyuan Z, Kwak M, Bergholtz H, Su Y, Ding L, Russnes HG, Richardson AL, Babski K, Kim EMH, et al. Abstract A15: Immune-related changes in breast cancer tumor evolution Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-A15 |
0.361 |
|
| 2018 |
Ding L, Su Y, Ekram M, Huh SJ, Bloushtain-Qimron N, Choudhury S, Hines W, Yao J, Bissell M, Polyak K. Abstract B62: Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in DCIS (ductal carcinoma in situ) Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-B62 |
0.447 |
|
| 2018 |
Alcazar CRGd, Huh S, Ekram MB, Trinh A, Liu LL, Beca F, Xiaoyuan Z, Kwak M, Bergholtz H, Su Y, Ding L, Russnes HG, Richardson AL, Babski K, Kim EMH, et al. Abstract A21: Characterization of the immune environment in the in situ to invasive breast carcinoma transition Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-A21 |
0.336 |
|
| 2018 |
Vohidov F, Andersen JN, Economides KD, Shipitsin MV, Burenkova O, Gallagher NM, Sheih P, Golder M, Liu J, Dahlberg WK, Nguyen HV, Ehrlich DJ, Kim J, Huh SJ, Vangamudi B, et al. Abstract LB-062: Development of macromolecular prodrugs of BET-bromodomain inhibitors with superior anti-tumor efficacy that are T-cell sparing and devoid of systemic toxicity Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-062 |
0.44 |
|
| 2017 |
Gil Del Alcazar CR, Huh SJ, Ekram MB, Trinh A, Liu LL, Beca F, Zi X, Kwak M, Bergholtz H, Su Y, Ding L, Russnes HG, Richardson AL, Babski K, Min Hui Kim E, et al. Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition. Cancer Discovery. PMID 28652380 DOI: 10.1158/2159-8290.Cd-17-0222 |
0.386 |
|
| 2016 |
Huh SJ, Oh H, Peterson MA, Almendro V, Hu R, Bowden M, Lis RT, Cotter MB, Loda M, Barry WT, Polyak K, Tamimi RM. The proliferative activity of mammary epithelial cells in normal tissue predicts breast cancer risk in premenopausal women. Cancer Research. PMID 26941287 DOI: 10.1158/0008-5472.Can-15-1927 |
0.33 |
|
| 2014 |
Zou MR, Cao J, Liu Z, Huh SJ, Polyak K, Yan Q. Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes. The Journal of Biological Chemistry. 289: 17620-33. PMID 24802759 DOI: 10.1074/Jbc.M114.570853 |
0.395 |
|
| 2011 |
Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, et al. The JAK2/STAT3 signaling pathway is required for growth of CD44âºCD24â» stem cell-like breast cancer cells in human tumors. The Journal of Clinical Investigation. 121: 2723-35. PMID 21633165 DOI: 10.1172/Jci44745 |
0.443 |
|
| 2011 |
Nguyen N, Sharma A, Nguyen N, Sharma AK, Desai D, Huh SJ, Amin S, Meyers C, Robertson GP. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prevention Research (Philadelphia, Pa.). 4: 248-58. PMID 21097713 DOI: 10.1158/1940-6207.Capr-10-0106 |
0.628 |
|
| 2010 |
Huh SJ, Chen YL, Friedman SL, Liao J, Huang HJ, Cavenee WK, Robertson GP. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment. Journal of the National Cancer Institute. 102: 1131-47. PMID 20660366 DOI: 10.1093/Jnci/Djq218 |
0.63 |
|
| 2010 |
Huh SJ, Liang S, Sharma A, Dong C, Robertson GP. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Research. 70: 6071-82. PMID 20610626 DOI: 10.1158/0008-5472.Can-09-4442 |
0.605 |
|
| 2010 |
Huh SJ, Chung CY, Sharma A, Robertson GP. Macrophage inhibitory cytokine-1 regulates melanoma vascular development. The American Journal of Pathology. 176: 2948-57. PMID 20431030 DOI: 10.2353/Ajpath.2010.090963 |
0.607 |
|
| 2009 |
Sharma A, Sharma AK, Madhunapantula SV, Desai D, Huh SJ, Mosca P, Amin S, Robertson GP. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1674-85. PMID 19208796 DOI: 10.1158/1078-0432.Ccr-08-2214 |
0.628 |
|
| 2009 |
Sharma A, Nguyen N, Nguyen N, Sharma A, Desai D, Huh SJ, Amin S, Robertson GP. Abstract A93: Topical ISC‐4 for the prevention of melanoma Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A93 |
0.602 |
|
| 2008 |
Sharma AK, Sharma A, Desai D, Madhunapantula SV, Huh SJ, Robertson GP, Amin S. Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. Journal of Medicinal Chemistry. 51: 7820-6. PMID 19053750 DOI: 10.1021/Jm800993R |
0.636 |
|
| 2008 |
Madhunapantula SV, Desai D, Sharma A, Huh SJ, Amin S, Robertson GP. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. Molecular Cancer Therapeutics. 7: 1297-308. PMID 18483317 DOI: 10.1158/1535-7163.Mct-07-2267 |
0.649 |
|
| Show low-probability matches. |